# A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

> **NCT04953000** · — · COMPLETED · sponsor: **Takeda** · enrollment: 94 (actual)

## Conditions studied

- Hemophilia A

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04953000
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-19
- **Primary completion:** 2023-04-04
- **Final completion:** 2023-04-04
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2023-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04953000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04953000, "A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04953000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*